Jackson Square Partners’s Thermo Fisher Scientific TMO Stock Holding History

Jackson Square Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-520	Closed	-$263K	–	87
2023 Q3	$263K	Buy	520 +53	+11%	+$28.2K	0.01%	64
2023 Q2	$244K	Buy	467 +88	+23%	+$47.5K	0.01%	64
2023 Q1	$218K	Buy	379 +148	+64%	+$83.4K	0.01%	60
2022 Q4	$127K	Buy	+231	New	+$122K	﹤0.01%	64

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jackson Square Partners's TMO Position: Q4 2023 in Review

Jackson Square Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 520 shares — an estimated $263K sold.

Jackson Square Partners first reported a position in TMO in Q4 2022 and held it in 4 quarters. The position peaked at $263K in Q3 2023. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Jackson Square Partners reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Jackson Square Partners sold 520 Thermo Fisher Scientific shares in Q4 2023, an estimated $263K.
Jackson Square Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 4 quarters.
Jackson Square Partners's Thermo Fisher Scientific position peaked at $263K in Q3 2023.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Jackson Square Partners's 13F filing for Q4 2023, filed 8 Feb 2024.